Study: Cooling temperature for therapeutic hypothermia
In unconscious patients who survived an out-of-hospital cardiac arrest, cooling to 33 degrees C was no more beneficial than 36 degrees C, according to…
Web Exclusives
Independent NP practice in retail clinics saves money
According to a study in Health Affairs, the cost per episode treated by nurse practitioners (NPs) in retail clinics was lower in states where…
Lowering BP prevents cardiovascular events in people with kidney disease
Lowering blood pressure (BP) is a highly effective and affordable way to prevent cardiovascular events like heart attack and stroke among people with chronic…
Vagus nerve stimulation may reduce HF symptoms
A global, multicenter randomized clinical trial called INOVATE-HF (INcrease Of VAgal TonE in chronic Heart Failure) is investigating the safety and efficacy of an…
Four new guidelines from AHA, ACC
The American Heart Association and the American College of Cardiology have released four guidelines related to preventing cardiovascular disease: cholesterol, obesity, lifestyle, assessment of…
Recall of MedStream Programmable Infusion Pump and Refill Kits
On Oct. 23, the U.S. Food and Drug Administration (FDA) noted that Codman & Shrutleff, Inc., has recalled its MedStream Programmable Pump and MedStream…
FDA expands access to artificial heart valve to inoperable patients
On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available…
FDA approves Liposorber Apheresis System for pediatric use
On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS)…
FDA approved Adempas for pulmonary hypertension
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Read more.
Recall of metoclopramide and ondansetron injections
On Oct. 2, the U.S. Food and Drug Administration (FDA) noted that Hospira has recalled one lot of metoclopramide injection and two lost of…
FDA approves Brintellix for major depression
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Brintellix (vortioxetine) to treat adults with major depressive disorder. Read more.
Study: Antihypertensives decrease risk of Alzheimer disease
Diuretics, angiotensin-1 receptor blockers, and angiotensin-converting enzyme inhibitors seemed to reduce the risk of Alzheimer disease (AD), according to a study, published in Neurology,…
Study: Cooling temperature for therapeutic hypothermia
In unconscious patients who survived an out-of-hospital cardiac arrest, cooling to 33 degrees C was no more beneficial than 36 degrees C,…
Independent NP practice in retail clinics saves money
According to a study in Health Affairs, the cost per episode treated by nurse practitioners (NPs) in retail clinics was lower in…
Lowering BP prevents cardiovascular events in people with kidney disease
Lowering blood pressure (BP) is a highly effective and affordable way to prevent cardiovascular events like heart attack and stroke among people…
Vagus nerve stimulation may reduce HF symptoms
A global, multicenter randomized clinical trial called INOVATE-HF (INcrease Of VAgal TonE in chronic Heart Failure) is investigating the safety and efficacy…
Four new guidelines from AHA, ACC
The American Heart Association and the American College of Cardiology have released four guidelines related to preventing cardiovascular disease: cholesterol, obesity, lifestyle,…
Recall of MedStream Programmable Infusion Pump and Refill Kits
On Oct. 23, the U.S. Food and Drug Administration (FDA) noted that Codman & Shrutleff, Inc., has recalled its MedStream Programmable Pump…
FDA expands access to artificial heart valve to inoperable patients
On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the…
FDA approves Liposorber Apheresis System for pediatric use
On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental…
FDA approved Adempas for pulmonary hypertension
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension.…
Recall of metoclopramide and ondansetron injections
On Oct. 2, the U.S. Food and Drug Administration (FDA) noted that Hospira has recalled one lot of metoclopramide injection and two…
FDA approves Brintellix for major depression
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Brintellix (vortioxetine) to treat adults with major depressive disorder. Read more.
Study: Antihypertensives decrease risk of Alzheimer disease
Diuretics, angiotensin-1 receptor blockers, and angiotensin-converting enzyme inhibitors seemed to reduce the risk of Alzheimer disease (AD), according to a study, published…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.